Page 4 - Sohini Das

RPG Life Sciences eyes GLP-1 entry, US market via plant acquisitions

The company sharpens its domestic specialty formulations focus and looks to scale APIs through acquisitions, while planning partnership-led GLP-1 launches

Biocon to integrate Biocon Biologics in $5.5-bn tranx, pivots away from IPO

Proposed transaction will result in Biocon Biologics becoming a wholly-owned subsidiary of Biocon, simplifying the group structure, and strengthening the consolidated balance sheet

SKF India Industrial expects top line to nearly double in 5 years

SKF India Industrial expects revenue to scale to about ₹4,500 crore in five years, with margins improving post-2028 as a Pune plant-led capex cycle is completed and efficiency rises

Biocon board to weigh BBL stake buyout, fundraising options on December 6

Biocon's board will meet on December 6 to consider acquiring Biocon Biologics shares from minority investors through cash or a share swap, and to approve fundraising options such as QIP, rights issue

Manipal Health readies $1 bn IPO; targets $12-15 bn valuation

Valuation of India's largest hospital network is around $12-15 bn. The Issue will comprise fresh issue of shares and a small portion as OFS

Pharmaceutical sector set to gain from rupee fall despite API dependence

Exporters like Sun Pharma, Dr Reddy's may see 7-8% revenue lift, yet margins pressured by high raw material import costs

Auto industry weighed down by forex pressure as rupee depreciates

With the rupee weakening against the euro and dollar, luxury and mass-market automakers are preparing steep price hikes as rising import and semiconductor costs squeeze margins

India e-2W registrations cross 1.18 million; TVS leads, Ola slips in Nov

India's electric two-wheeler market grew 10% in January-November 2025 to 1.18 million registrations. TVS and Bajaj led, while Ola fell sharply in November, Vahan data shows

Sun Pharma launches blockbuster plaque psoriasis drug Ilumya in India

Ilumya, a novel biologic treatment that selectively inhibits IL-23, has already established itself as a blockbuster drug internationally, with presence across 35 countries, including the US

NCDC aims to deploy real time data, AI to boost disease surveillance

Officials say upcoming predictive model will integrate AI surveillance, climatic and population movement patterns to anticipate outbreak trajectories

What lies ahead: The most anticipated luxury car and bike launches

India's luxury auto scene is shifting into high gear, with superbikes, EVs, and reimagined icons set to redefine performance and design. The season ahead promises pure velocity wrapped in luxury

The next turn: How taxes and trade deals are reshaping luxury car prices

GST 2.0, which levies a flat 40 per cent tax on luxury vehicles, has spurred renewed enthusiasm. Prices have fallen by 6-8 per cent

Rainbow Children's Hospital to add 900 beds, with half coming up in NCR

Rainbow Children's Hospital Group is accelerating its pan-India expansion with nearly 900 new beds planned over three years, half of which will come up in the NCR

18 nations and rising: India builds global support for its Pharmacopoeia

Industry representatives argue that global acceptance of Indian Pharmacopoeia could significantly reduce export costs and make Indian drugs more affordable to developing nations

What makes long Covid long: New evidence raises concern and diagnostic hope

Research finds persistent immune and clotting abnormalities, underscoring the scale of India's long Covid burden and its impact on heart and vascular health

Elderly may account for 25% of India's pharma market in 2-3 decades

Seniors are 10% of India, but already 17% of its pharma market

India-US lane feeling pricing squeeze: TVS Supply Chain Solutions MD

TVS SCS MD Ravi Viswanathan outlines growth plans, US market deals, margin improvement and how restructuring and outsourcing trends will shape the company's next phase

Biorad Medisys works on 'pacemaker' for managing diabetes with VNS tech

Uses vagus nerve stimulation tech to modulate blood-glucose levels

TaMo evaluating both CNG, hybrids for larger cars, SUVs above 4 metres

Tata Motors says its strong EV-CNG mix keeps it well within CAFÉ compliance, but it is studying CNG use up to 4.3 metres and exploring strong hybrids for larger cars and SUVs if segment competitivenes

Lilly's investment reflects long-term commitment to India: Winselow Tucker

Eli Lilly invests $1B in India as Mounjaro succeeds, Hyderabad site to boost global supply and innovation